Zipeng Lu

3.4k total citations · 1 hit paper
104 papers, 2.2k citations indexed

About

Zipeng Lu is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Zipeng Lu has authored 104 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 38 papers in Surgery and 36 papers in Molecular Biology. Recurrent topics in Zipeng Lu's work include Pancreatic and Hepatic Oncology Research (57 papers), Pancreatitis Pathology and Treatment (20 papers) and Cancer-related molecular mechanisms research (11 papers). Zipeng Lu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (57 papers), Pancreatitis Pathology and Treatment (20 papers) and Cancer-related molecular mechanisms research (11 papers). Zipeng Lu collaborates with scholars based in China, United States and Germany. Zipeng Lu's co-authors include Yi Miao, Kuirong Jiang, Jishu Wei, Pengfei Wu, Baobao Cai, Lei Tian, Hao Yuan, Jie Yin, Wentao Gao and Min Tu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Cancer Cell.

In The Last Decade

Zipeng Lu

95 papers receiving 2.2k citations

Hit Papers

Tumor cell-intrinsic epigenetic dysregulation shapes canc... 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zipeng Lu China 25 1.2k 867 848 415 335 104 2.2k
Zongyou Chen China 27 991 0.8× 438 0.5× 684 0.8× 384 0.9× 308 0.9× 97 2.1k
Guolin Li China 23 1.2k 1.0× 507 0.6× 855 1.0× 392 0.9× 130 0.4× 39 2.1k
Di Lu China 22 869 0.7× 572 0.7× 478 0.6× 533 1.3× 384 1.1× 88 2.2k
Dan Liao China 18 1.4k 1.1× 833 1.0× 753 0.9× 374 0.9× 112 0.3× 35 2.2k
Yuji Mishima Japan 29 1.1k 0.9× 946 1.1× 430 0.5× 451 1.1× 90 0.3× 94 2.3k
Aiping Luo China 29 1.8k 1.5× 598 0.7× 998 1.2× 296 0.7× 226 0.7× 66 2.5k
Xinlong Yan China 23 1.7k 1.4× 426 0.5× 1.1k 1.3× 174 0.4× 293 0.9× 46 2.8k
Xipeng Wang China 28 1.6k 1.3× 480 0.6× 1.1k 1.3× 826 2.0× 79 0.2× 66 2.8k
Jasgit C. Sachdev United States 23 1.7k 1.4× 1.6k 1.8× 947 1.1× 483 1.2× 155 0.5× 126 3.4k
Tao Fang China 25 1.0k 0.8× 457 0.5× 446 0.5× 308 0.7× 106 0.3× 53 1.8k

Countries citing papers authored by Zipeng Lu

Since Specialization
Citations

This map shows the geographic impact of Zipeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zipeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zipeng Lu more than expected).

Fields of papers citing papers by Zipeng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zipeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zipeng Lu. The network helps show where Zipeng Lu may publish in the future.

Co-authorship network of co-authors of Zipeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zipeng Lu. A scholar is included among the top collaborators of Zipeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zipeng Lu. Zipeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Zipeng, et al.. (2025). Geopolitical shock and local government debt risk. Finance research letters. 82. 107572–107572.
2.
Lu, Zipeng, et al.. (2024). Efficiency evaluation of dual-energy CT to predict the postoperative early recurrence of pancreatic ductal adenocarcinoma. Pancreatology. 24(7). 1123–1132. 1 indexed citations
3.
Wang, Guangfu, Jin Chen, Kai Zhang, et al.. (2024). USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. Cell Death and Differentiation. 32(4). 702–713. 3 indexed citations
4.
Wang, Guangfu, Jin Chen, Jinfan Zhang, et al.. (2023). High pyroptosis activity in pancreatic adenocarcinoma: poor prognosis and oxaliplatin resistance. APOPTOSIS. 29(3-4). 344–356. 1 indexed citations
6.
Lu, Zipeng, Qiang Li, Kuirong Jiang, et al.. (2023). A Risk Score for Predicting the Necessity of Surgical Necrosectomy in the Treatment of Infected Necrotizing Pancreatitis. Journal of Gastrointestinal Surgery. 27(10). 2145–2154. 4 indexed citations
8.
Cai, Baobao, Frank Bergmann, Zipeng Lu, et al.. (2022). A histopathological study of artery wall involvement in pancreatic cancer surgery. Langenbeck s Archives of Surgery. 407(8). 3501–3511. 4 indexed citations
9.
Xu, Dong, Pengfei Wu, Kai Zhang, et al.. (2022). The short-term outcomes of distal pancreatectomy with portal vein/superior mesenteric vein resection. Langenbeck s Archives of Surgery. 407(5). 2161–2168. 7 indexed citations
10.
Shen, Peng, Taoyue Yang, Qun Chen, et al.. (2021). CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing. Molecular Cancer. 20(1). 51–51. 92 indexed citations
11.
Li, Qiang, Zipeng Lu, Kuirong Jiang, et al.. (2021). From “step-up” to “step-jump”: a leap-forward intervention for infected necrotizing pancreatitis. Chinese Medical Journal. 135(3). 285–287. 7 indexed citations
12.
Li, Xiaoxue, Mingyue Hu, Yu Ma, et al.. (2020). CircRHOT1 mediated cell proliferation, apoptosis and invasion of pancreatic cancer cells by sponging miR‐125a‐3p. Journal of Cellular and Molecular Medicine. 24(17). 9881–9889. 19 indexed citations
13.
Barrera, Lawrence N., A.G. Evans, Brian R. Lane, et al.. (2020). Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties. Cancer Research. 80(13). 2861–2873. 25 indexed citations
14.
Zhang, Kai, Xiao Wang, Kuirong Jiang, et al.. (2020). Utilization of Mobile Application for Better Implementation of Good Clinical Practice in a Biorepository Sample Collection Process: Functions of PancMoBio in Biobanking. Biopreservation and Biobanking. 18(2). 46–52. 1 indexed citations
15.
Lu, Zipeng, et al.. (2018). Insulin enhanced KRAS-dependent migration and invasion via SSTR2/AKT axis. HPB. 20. S577–S578. 1 indexed citations
16.
Dong, Qian, Lei Tian, Zipeng Lu, & Yi Miao. (2018). Cytokine Profiling and Orthotopic Xenografing of Pancreatic Stellate Cells. Methods in molecular biology. 1882. 157–160. 1 indexed citations
17.
He, Yuan, Hao Hu, Yan‐Dong Wang, et al.. (2018). ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation. Cellular Physiology and Biochemistry. 48(2). 838–846. 209 indexed citations
18.
Tian, Lei, Zipeng Lu, & Yi Miao. (2018). Primary Cultures for Pancreatic Stellate Cells (PSCs). Methods in molecular biology. 1882. 149–155. 3 indexed citations
19.
Zhou, Xin, Zipeng Lu, Tongshan Wang, et al.. (2018). Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis. Gene. 673. 181–193. 97 indexed citations
20.
Lu, Zipeng, Jie Yin, Jishu Wei, et al.. (2016). Small amounts of tissue preserve pancreatic function. Medicine. 95(46). e5274–e5274. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026